REQUEST A DEMO
Total
USD $0.00
Search more companies

Auspik Pharmaceuticals Private Limited (India)

Main Activities: Other Business Support Services
Full name: Auspik Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Auspik Pharmaceuticals Private Limited is an enterprise in India, with the main office in Mumbai. It operates in the Other Business Support Services industry. The company was established on June 11, 2010. From the latest financial highlights, Auspik Pharmaceuticals Private Limited reported a net sales revenue increase of 152.03% in 2024. Its total assets grew by 147.13% over the same period. In, 2024, the company’s net profit margin decreased by 0.27%.

Legal Address
Sarover 303, Vasant Housing Complex Mahaveer Nagar, Kandivali West
Mumbai; Maharashtra; Postal Code: 400067

Contact Details: Purchase the Auspik Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Auspik Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Auspik Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
June 11, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Auspik Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
152.03%
Total Operating Revenue
155.49%
Operating Profit
53.26%
EBITDA
59.95%
Net Profit/Loss for the Period
83.11%
Total Assets
147.13%
Total Equity
38.32%
Operating Profit Margin
-0.94%
Net Profit Margin
-0.27%
Return on Equity (ROE)
6.77%
Debt / Equity
-45.52%
Quick Ratio
-0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?